Clinical evaluation study of Beta-glucan assay
Not Applicable
- Conditions
- invasive fungal infections
- Registration Number
- JPRN-UMIN000050121
- Lead Sponsor
- Osaka Metropolitan University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
Not provided
Exclusion Criteria
Patients whose consent cannot be obtained or who are deemed inappropriate by the physician in charge
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary endpoint: Diagnostic performance of Beta-glucan assay reagents We will evaluate the application performance of each reagent by measuring specimens suspected of having deep-seated mycosis with each company's Beta-glucan assay reagent and comparing the results with the diagnostic results in a retrospective manner.
- Secondary Outcome Measures
Name Time Method Secondary endpoint: Correlation of Beta-glucan assay reagents from various companies